Fundraising Fox
/Companies
Sign in

ZoMedica Pharmaceuticals

OTC: ZOMDF

Ann Arbor, US · Founded 2015 · Alberta, Canada corporation

Find your way into ZoMedica Pharmaceuticals

52 people in our graph share verified history with the ZoMedica Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.

Gloria Houunlockedknows Jerry Solensky · together at Indymac Bank (overlapped)
×3knows the team · via Indymac Bank
knows the team · via Zomedica
×4knows the team · via Yamaha Motor Co., Ltd.
×3knows the team · via Western Michigan University

Zomedica develops diagnostic products and therapeutic technologies for clinical veterinarians, spanning diagnostics, pain and inflammation therapy, shock wave regeneration, and hemostatic products. It operates a family of animal health brands serving veterinary practices and their patients.

BiotechHealthtechMedical Devices

Founders & leadership

ZoMedica Pharmaceuticals was founded in 2015 by Jerry Solensky.

JSJerry Solensky
Jerry SolenskyFounderJerry Solensky is Chief Executive Officer and Director of ZoMedica Pharmaceuticals, with background in finance, sales, marketing, business development, and capital markets, as well as over 800 observation hours in pre-veterinary medicine.
WM
William MacArthurExecutive
SM
Stephanie MorleyExecutive
SRShameze Rampertab
Shameze RampertabExecutive

Board

JL
Jim LebarBoard director
JR
Jeffrey RoweBoard director
RJ
Rodney J. WilliamsBoard director

Reported raises · per SEC filings

Form D private placements

$28.5M disclosed across 8 of 9 rounds · 2015–2020

▶Undisclosed amountofferedFeb 2020 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Johnny D. PowersDirector
  • Bruk HerbstExecutive Officer
  • James LeBarDirector
  • Rodney J. WilliamsDirector
  • Shameze RampertabExecutive Officer, Director
  • Jeffrey RoweDirector
  • Stephanie MorleyExecutive Officer
Placement agents
H.C. Wainwright & Co., LLC
First sale
Feb 2020
Incorporated
Corporation, Alberta, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedMay 2019 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rodney J. WilliamsDirector
  • Jeffrey RoweDirector
  • Shameze RampertabExecutive Officer, Director
  • Stephanie MorleyExecutive Officer
  • James LeBarDirector
  • Bruk HerbstExecutive Officer
  • Gerald SolenskyExecutive Officer, Director
Offering amount
$20M
Amount sold
$12M
First sale
May 2019
Incorporated
Corporation, Alberta, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$550KraisedMay 2018 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerald SolenskyExecutive Officer, Director
  • Stephanie MorleyExecutive Officer
  • Bruk HerbstExecutive Officer
  • James Le BarDirector
  • Jane EaglesonDirector
  • Robert DiMarzoExecutive Officer
  • Jeffrey RoweDirector
  • Shameze RampertabExecutive Officer, Director
  • Thomas RobitailleDirector
  • Rodney J. WilliamsDirector
Offering amount
$10M
Amount sold
$550K
First sale
May 2018
Incorporated
Corporation, Alberta, Canada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedMay 2018 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephanie MorleyExecutive Officer
  • Shameze RampertabExecutive Officer, Director
  • Bruk HerbstExecutive Officer
  • Thomas RobitailleDirector
  • Robert DiMarzoExecutive Officer
  • Jane EaglesonDirector
  • Jeffrey RoweDirector
  • James Le BarDirector
  • Gerald SolenskyExecutive Officer, Director
  • Rodney J. WilliamsDirector
Offering amount
$1.3M
Amount sold
$1.3M
First sale
May 2018
Incorporated
Corporation, Alberta, Canada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.3MraisedAug 2017 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert DiMarzoExecutive Officer
  • Shameze RampertabExecutive Officer, Director
  • Tom RobitailleDirector
  • Jeffrey RoweDirector
  • Jane EaglesonDirector
  • Gerald SolenskyExecutive Officer, Director
  • Rodney J. WilliamsDirector
  • Bruk HerbstExecutive Officer
  • Stephanie MorleyExecutive Officer
  • Jim LebarDirector
Offering amount
$10.1M
Amount sold
$3.3M
First sale
Jul 2017
Incorporated
Corporation, Alberta, Canada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$866KraisedJan 2017 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Tom RobitailleDirector
  • Jim LebarDirector
  • Gerald SolenskyExecutive Officer, Director
  • Rodney J. WilliamsDirector
  • Shameze RampertabExecutive Officer, Director
  • Jane EaglesonDirector
  • Jeffrey RoweDirector
  • William MacArthurExecutive Officer, Director
  • Stephanie MorleyExecutive Officer
Offering amount
$7.4M
Amount sold
$866K
First sale
Dec 2016
Incorporated
Corporation, Alberta, Canada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.7MraisedJan 2017 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • William MacArthurExecutive Officer, Director
  • Rodney J. WilliamsDirector
  • Jim LebarDirector
  • Stephanie MorleyExecutive Officer
  • Jeffrey RoweDirector
  • Shameze RampertabExecutive Officer, Director
  • Jane EaglesonDirector
  • Tom RobitailleDirector
  • Gerald SolenskyExecutive Officer, Director
Offering amount
$3.7M
Amount sold
$3.7M
First sale
Dec 2016
Incorporated
Corporation, Alberta, Canada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.9MraisedSep 2016 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey RoweDirector
  • William MacArthurExecutive Officer, Director
  • Jim LebarDirector
  • Gerald SolenskyExecutive Officer, Director
  • Stephanie MorleyExecutive Officer
  • Shameze RampertabExecutive Officer, Director
  • Rodney J. WilliamsDirector
Offering amount
$3.9M
Amount sold
$3.9M
First sale
Aug 2016
Incorporated
Corporation, Alberta, Canada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does ZoMedica Pharmaceuticals do?
Zomedica develops diagnostic products and therapeutic technologies for clinical veterinarians, spanning diagnostics, pain and inflammation therapy, shock wave regeneration, and hemostatic products. It operates a family of animal health brands serving veterinary practices and their patients.
Who founded ZoMedica Pharmaceuticals?
ZoMedica Pharmaceuticals was founded by Jerry Solensky in 2015.
How much funding has ZoMedica Pharmaceuticals raised?
ZoMedica Pharmaceuticals has disclosed $28.5M raised across 8 of its 9 known rounds.
Where is ZoMedica Pharmaceuticals headquartered?
ZoMedica Pharmaceuticals is headquartered in Ann Arbor, US.